Total Valuation
Biomolecular Life Holdings Inc has a market cap or net worth of $474.65K. The enterprise value is $421.91K.
Market Cap$474.65K
Enterprise Value$421.91K
Share Statistics
Biomolecular Life Holdings Inc has 1,054,774 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,054,774
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Biomolecular Life Holdings Inc’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count1
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Biomolecular Life Holdings Inc is ―. Biomolecular Life Holdings Inc’s PEG ratio is -0.00431.
PE Ratio―
PS Ratio0.00
PB Ratio-0.24
Price to Fair Value―
Price to FCF-42.77
Price to Operating Cash Flow―
PEG Ratio-0.00431
Income Statement
In the last 12 months, Biomolecular Life Holdings Inc had revenue of ― and earned ― in profits. Earnings per share was ―.
Revenue―
Gross Profit―
Operating Income―
Pretax Income―
Net Income―
EBITDA―
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Biomolecular Life Holdings Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta73.41
52-Week Price Change-28.46%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Biomolecular Life Holdings Inc upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Biomolecular Life Holdings Inc as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Biomolecular Life Holdings Inc has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
Biomolecular Life Holdings Inc EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Biomolecular Life Holdings Inc has ― in cash and marketable securities with $2.11M in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt$2.11M
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Biomolecular Life Holdings Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-110.00%